GL Capital Group Privatises Its Portfolio Company, SciClone Pharma
10 Jul 2024
US$ 19.00
GL Capital Group (GL) has recently completed the privatisation of the Hong Kong-listed SciClone Pharmaceuticals ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 02 May 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.